Coopting T cell proximal signaling molecules enables Boolean logic-gated CAR T cell control
Tousley, A. M.; Rotiroti, M. C.; Labanieh, L.; Rysavy, L. W.; Rietberg, S. P.; de la Serna, E. L.; Dalton, G. N.; Klysz, D.; Weber, E. W.; Kim, W.-J.; Xu, P.; Sotillo, E.; Dunn, A. R.; Mackall, C. L.; Majzner, R. G.
Show abstract
Introductory paragraphWhile CAR T cells have altered the treatment landscape for B cell malignancies, the risk of on-target, off-tumor toxicity has hampered their development for solid tumors because most target antigens are shared with normal cells1,2. Researchers have attempted to apply Boolean logic gating to CAR T cells to prevent on-target, off-tumor toxicity3-7; however, a truly safe and effective logic-gated CAR has remained elusive8. Here, we describe a novel approach to CAR engineering in which we replace traditional ITAM-containing CD3{zeta} domains with intracellular proximal T cell signaling molecules. We demonstrate that certain proximal signaling CARs, such as a ZAP-70 CAR, can activate T cells and eradicate tumors in vivo while bypassing upstream signaling proteins such as CD3{zeta}. The primary role of ZAP-70 is to phosphorylate LAT and SLP-76, which form a scaffold for the propagation of T cell signaling. We leveraged the cooperative role of LAT and SLP-76 to engineer Logic-gated Intracellular NetworK (LINK) CAR, a rapid and reversible Boolean-logic AND-gated CAR T cell platform that outperforms other systems in both efficacy and the prevention of on-target, off-tumor toxicity. LINK CAR will dramatically expand the number and types of molecules that can be targeted with CAR T cells, enabling the deployment of these powerful therapeutics for solid tumors and diverse diseases such as autoimmunity9 and fibrosis10. In addition, this work demonstrates that the internal signaling machinery of cells can be repurposed into surface receptors, a finding that could have broad implications for new avenues of cellular engineering.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- LAG-3 blockade reactivates the CD8+ T cell expansion program to re-expand contracted clones in the tumor 98%
- Combinatorial immunotherapies overcome MYC-driven immune evasion 97%
- Agonistic CD40 antibody therapy induces tertiary lymphoid structures but impairs the response to immune checkpoint blockade in glioma 97%
Similar papers in this journal
Similar papers in this journal
- In vivo affinity maturation of the HIV-1 Env-binding domain of CD4 97%
- Cooperative phagocytosis underlies macrophage immunotherapy of solid tumours and initiates a broad anti-tumour IgG response 97%
- Self-Organization of Sinusoidal Vessels in Pluripotent Stem Cell-derived Human Liver Bud Organoids 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.